Company Filing History:
1 out of 5 
1 out of 14 Years Active: 2015
Title: Fanxin Ma: Innovator in Monoclonal Antibody Development
Introduction
Fanxin Ma is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions for medical treatments, showcasing his expertise and dedication to advancing healthcare.
Latest Patents
Fanxin Ma holds a patent for an "Anti-VEGF monoclonal antibody and pharmaceutical composition comprising said antibody." This invention provides an anti-VEGF monoclonal antibody, which includes specific amino acid sequences in its variable regions. The antibody can be produced by a cell line with the preservation number of CGMCC NO. 3233. The invention also outlines the use of this antibody for manufacturing medicaments aimed at treating diseases related to VEGF, along with associated pharmaceutical compositions, agents, kits, and chips.
Career Highlights
Throughout his career, Fanxin Ma has worked with notable companies in the pharmaceutical industry. He has been associated with Jiangsu Simcere Pharmaceutical R&D Co., Ltd and Apexigen, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Fanxin Ma has collaborated with esteemed colleagues, including Pierre Li and Yaohuang Ke. These partnerships have further enhanced his research and development efforts in the field of monoclonal antibodies.
Conclusion
Fanxin Ma's contributions to the field of biotechnology, particularly through his patent on anti-VEGF monoclonal antibodies, highlight his role as an innovator in medical science. His work continues to pave the way for advancements in treatment options for various diseases.